Historical salary details - Dr. Michael Harvey Davidson, M.D., Chief Executive Officer and Director, NewAmsterdam Pharma Company NV
Dr. Michael Harvey Davidson, M.D. is the Chief Executive Officer and Director of NewAmsterdam Pharma Company NV. They also hold 1 other positions in and Silence Therapeutics Plc - ADR.
Dr. Michael Harvey Davidson, M.D.
Chief Executive Officer and Director
-
Gross Remuneration
-
Current Company
NewAmsterdam Pharma Company NV
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | NewAmsterdam Pharma Company NV | Chief Executive Officer and Director | - | - |
| 2024 | Silence Therapeutics Plc - ADR | Independent Director | - | - |
| 2023 | Tenax Therapeutics Inc | Independent Director | 57.5 K | -4.3 % |
| 2023 | NewAmsterdam Pharma Company NV | Chief Executive Officer and Director | - | - |
| 2022 | Lisata Therapeutics Inc | Independent Director | 97.8 K | -13.8 % |
| 2022 | Tenax Therapeutics Inc | Independent Director | 60.1 K | 11.3 % |
| 2022 | NewAmsterdam Pharma Company NV - Warrants (15/11/2027) | Chief Executive Officer and Director | - | - |
| 2022 | Silence Therapeutics Plc - ADR | Independent Director | - | - |
| 2022 | Lisata Therapeutics Inc | Independent Director | - | - |
| 2021 | Lisata Therapeutics Inc | Independent Director | 113.5 K | -20.1 % |
| 2021 | Silence Therapeutics Plc - ADR | Independent Director | 54 K | - |
| 2021 | Tenax Therapeutics Inc | Independent Director | 54.0 K | - |
| 2021 | NewAmsterdam Pharma Company NV | Chief Executive Officer and Director | - | - |
| 2020 | Lisata Therapeutics Inc | Independent Director | 142.0 K | - |
| 2020 | Silence Therapeutics Plc - ADR | Independent Director | - | - |
| 2020 | Tenax Therapeutics Inc | Independent Director | - | - |